記住我
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing [Internet]. 2019 Jan 1 [cited 2022 Jul 26];48(1):16–31. Available from: https://pubmed.ncbi.nlm.nih.gov/30312372/.
Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement. Obes Facts. 2022;15(3):321–35.
Article PubMed PubMed Central Google Scholar
de Luis Román D, Vallo FG, Gómez JC, Gómez JJL, Santabalbina FJT, Rolo GG, et al. Decreased muscle mass in type-2 diabetes. A hidden comorbidity to consider. Nutr Hosp [Internet]. 2023 Jan 1 [cited 2023 Jun 13];40(1):59–66. Available from: https://pubmed.ncbi.nlm.nih.gov/36633517/.
Giha HA, Alamin OAO, Sater MS. Diabetic sarcopenia: metabolic and molecular appraisal. Acta Diabetol [Internet]. 2022 Aug 1 [cited 2023 Jul 27;59(8):989–1000. Available from: https://pubmed.ncbi.nlm.nih.gov/35429264/.
Seok WP, Goodpaster BH, Jung SL, Kuller LH, Boudreau R, De Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 Diabetes. Diabetes Care. 2009;32(11):1993–7.
Jungert A, Eichner G, Neuhäuser-Berthold M. Trajectories of body composition during advanced aging in consideration of diet and physical activity: A 20-year longitudinal study. Nutrients [Internet]. 2020 Nov 25 [cited 2022 Jun 12];12(12):3626. Available from: https://www.mdpi.com/2072-6643/12/12/3626/htm.
JafariNasabian P, Inglis JE, Reilly W, Kelly OJ, Ilich JZ. Aging human body: Changes in bone, muscle and body fat with consequent changes in nutrient intake. J Endocrinol [Internet]. 2017 Jul 1 [cited 2022 Jun 12;234(1):R37-51. Available from: https://joe.bioscientifica.com/view/journals/joe/234/1/R37.xml.
Viña J, Borras C, Gomez-Cabrera MC. A free radical theory of frailty. Free Radic Biol Med. 2018;124:358–63.
Al-Sofiani ME, Ganji SS, Kalyani RR. Body composition changes in Diabetes and aging. J Diabetes Complications. 2019;33(6):451–9.
Article PubMed PubMed Central Google Scholar
Park SW, Goodpaster BH, Strotmeyer ES, De Rekeneire N, Harris TB, Schwartz AV, et al. Decreased muscle strength and quality in older adults with type 2 Diabetes: the health, aging, and body composition study. Diabetes. 2006;55(6):1813–8.
Article CAS PubMed Google Scholar
Alabadi B, Civera M, De la Rosa A, Martinez-Hervas S, Gomez-Cabrera MC, Real JT. Frailty is associated with oxidative stress in older patients with type 2 Diabetes. Nutrients. 2021;13(11):1–13.
Campins L, Camps M, Riera A, Pleguezuelos E, Yebenes JC, Serra-Prat M. Oral drugs related with muscle wasting and sarcopenia. A Review Pharmacology [Internet]. 2017 Jan 25 [cited 2023 Jun 15;99(1–2):1–8. https://doi.org/10.1159/000448247.
Seok WP, Goodpaster BH, Jung SL, Kuller LH, Boudreau R, De Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care [Internet]. 2009 Nov [cited 2022 Jun 11];32(11):1993–7. Available from: https://pubmed.ncbi.nlm.nih.gov/19549734/.
Abbatecola AM, Ferrucci L, Ceda GP, Russo CR, Lauretani F, Bandinelli S, et al. Insulin resistance and muscle strength in older persons. J Gerontol Ser A [Internet]. 2005 Oct 1 [cited 2023 Jun 15];60(10):1278–82. https://doi.org/10.1093/gerona/60.10.1278.
Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol [Internet]. 2001 [cited 2023 Jun 15;3(11):1014–9. Available from https://pubmed.ncbi.nlm.nih.gov/11715023/.
Mori H, Kuroda A, Ishizu M, Ohishi M, Takashi Y, Otsuka Y, et al. Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes. J Diabetes Investig [Internet]. 2019 Sep 1 [cited 2023 Jun 15;10(5):1332–40. Available from https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1111/jdi.13014.
Sugimoto K, Ikegami H, Takata Y, Katsuya T, Fukuda M, Akasaka H, et al. Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM Study. J Am Med Dir Assoc [Internet]. 2021;22(4):834–838.e1. https://doi.org/10.1016/j.jamda.2020.11.003.
Hiromine Y, Noso S, Rakugi H, Sugimoto K, Takata Y, Katsuya T, et al. Poor glycemic control rather than types of diabetes is a risk factor for sarcopenia in diabetes mellitus: The MUSCLES-DM study. J Diabetes Investig [Internet]. 2022 Nov 1 [cited 2023 May 29;13(11):1881–8. Available from: https://pubmed.ncbi.nlm.nih.gov/35796583/.
de Luis D, Primo D, Izaola O, Gómez Hoyos E, López Gómez JJ. Relationship of circulating resistin levels with muscle mass determined by bioelectrical impedance in females with obesity. Endocrinol Diabetes Nutr [Internet]. 2023 Aug [cited 2023 Aug 30;70(7):468–75. Available from: https://pubmed.ncbi.nlm.nih.gov/37516610/.
Sugimoto K, Tabara Y, Ikegami H, Takata Y, Kamide K, Ikezoe T, et al. Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus. J Diabetes Investig [Internet]. 2019 Nov 1 [cited 2023 Jun 13;10(6):1471–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31074209/.
Primo D, Izaola O, López Gómez JJ, De Luis D. Correlation of the phase angle with muscle ultrasound and quality of life in obese females. Dis Markers [Internet]. 2022 [cited 2023 Aug 30];2022. Available from: https://pubmed.ncbi.nlm.nih.gov/35983408/.
Wu CN, Tien KJ. The impact of antidiabetic agents on sarcopenia in type 2 diabetes: a literature review. J Diabetes Res. 2020;2020.
Pan R, Zhang Y, Wang R, Xu Y, Ji H, Zhao Y. Effect of SGLT-2 inhibitors on body composition in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. PLoS One [Internet]. 2022 Dec 1 [cited 2023 May 30];17(12):e0279889. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279889.
Zhang S, Qi Z, Wang Y, Song D, Zhu D. Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne) [Internet]. 2023 [cited 2023 Jul 27];14. Available from: https://pubmed.ncbi.nlm.nih.gov/37465122/.
Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, et al. Exercise management in type 1 diabetes: A consensus statement. Lancet Diabetes Endocrinol. 2017;5(5):377–90.
Carretero Gómez J, Galeano Fernández TF, Vidal Ríos AS, Pérez Palacios MR, García García GM, García Carrasco C, et al. Malnutrition and sarcopenia worsen short- and long-term outcomes in internal medicine inpatients. Postgrad Med J [Internet]. 2023 Mar 31 [cited 2023 Aug 30;99(1168):56–62. Available from: https://pubmed.ncbi.nlm.nih.gov/36828395/.
Serrano Valles C, López Gómez JJ, García Calvo S, Jiménez Sahagún R, Torres Torres B, Gómez Hoyos E, et al. Influence of nutritional status on hospital length of stay in patients with type 2 diabetes. Endocrinol Diabetes Nutr [Internet]. 2020;67(10):617–24. https://doi.org/10.1016/j.endinu.2020.05.004.
Zugasti A, Riestra M, Petrina E. Sarcopenia otra complicación crónica a considerar en personas con diabetes. Endocrinol Diabetes Nutr. 2022;69:32–32. (Espec Cong 1).
París AS, García JM, Gómez-Candela C, Burgos R, Martín Á, Matía P, et al. Malnutrition prevalence in hospitalized elderly diabetic patients. Nutr Hosp. 2013;28(3):592–9.
Sanz-París A, Martín-Palmero A, Gomez-Candela C, García-Almeida JM, Burgos-Pelaez R, Sanz-Arque A, et al. GLIM criteria at hospital admission predict 8-year all-cause mortality in elderly patients with type 2 diabetes mellitus: results from VIDA Study. JPEN J Parenter Enteral Nutr [Internet]. 2020 Nov 1 [cited 2023 Aug 30;44(8):1492–500. Available from: https://pubmed.ncbi.nlm.nih.gov/32026501/.
Lardiés-Sánchez B, Sanz-París A, Pérez-Nogueras J, Serrano-Oliver A, Torres-Anoro ME, Cruz-Jentoft AJ. Influence of nutritional status in the diagnosis of sarcopenia in nursing home residents. Nutrition [Internet]. 2017 Sep 1 [cited 2023 Aug 30];41:51–7. Available from: https://pubmed.ncbi.nlm.nih.gov/28760428/.
Sanz-Paris A, González-Fernandez M, Hueso-Del Río LE, Ferrer-Lahuerta E, Monge-Vazquez A, Losfablos-Callau F, et al. Muscle thickness and echogenicity measured by ultrasound could detect local sarcopenia and malnutrition in older patients hospitalized for hip fracture. Nutrients [Internet]. 2021 Jul 1 [cited 2023 Aug 30];13(7). Available from: https://pubmed.ncbi.nlm.nih.gov/34371911/.
Ahmed N, Choe Y, Mustad VA, Chakraborty S, Goates S, Luo M, et al. Impact of malnutrition on survival and healthcare utilization in Medicare beneficiaries with diabetes: A retrospective cohort analysis. BMJ Open Diabetes Res Care. 2018;6(1):1–9.
De Luis D, Primo D, Izaola O, Martinez A, Lopez Gomez JJ. Relationship between fat-free mass and metabolic syndrome in obese females. Eur Rev Med Pharmacol Sci [Internet]. 2023 [cited 2023 Aug 30];27(10):4648–55. Available from: https://pubmed.ncbi.nlm.nih.gov/37259765/.
Committee ADAPP. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care [Internet]. 2022 Jan 1 [cited 2022 Jul 19];45(Supplement_1):S17–38. Available from: https://diabetesjournals.org/care/article/45/Supplement_1/S17/138925/2-Classification-and-Diagnosis-of-Diabetes.
Fukuda T, Bouchi R, Takeuchi T, Nakano Y, Murakami M, Minami, I et al. Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: A cross-sectional study. BMJ Open Diabetes Res Care [Internet]. 2017 May 1 [cited 2023 May 30];5(1):e000404. Available from: https://drc.bmj.com/content/5/1/e000404.
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle [Internet]. 2016 Mar 1 [cited 2023 Jun 14];7(1):28–36. Available from: https://pubmed.ncbi.nlm.nih.gov/27066316/.
Parra-Rodríguez L, Szlejf C, García-González AI, Malmstrom TK, Cruz-Arenas E, Rosas-Carrasco O. Cross-cultural adaptation and validation of the spanish-language version of the SARC-F to assess sarcopenia in mexican community-dwelling older adults. J Am Med Dir Assoc [Internet]. 2016 Dec 1 [cited 2022 Jul 22;17(12):1142–6. Available from: http://www.jamda.com/article/S1525861016304236/fulltext.
Bahat G, Yilmaz O, Kiliç C, Oren MM, Karan MA. Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging [Internet]. 2018 Oct 1 [cited 2023 Jun 14;22(8):898–903. Available from: https://pubmed.ncbi.nlm.nih.gov/30272090/.
Yang M, Hu X, Xie L, Zhang L, Zhou J, Lin J, et al. Screening sarcopenia in community-dwelling older adults: SARC-F vs SARC-F combined with calf circumference (SARC-CalF). J Am Med Dir Assoc [Internet]. 2018 Mar 1 [cited 2023 Jun 15];19(3):277.e1–277.e8. Available from: http://www.jamda.com/article/S1525861017307016/fulltext.
Ruiz JG, Dent E, Morley JE, Merchant RA, Beilby J, Beard J, et al. Screening for and managing the person with frailty in primary care: ICFSR consensus guidelines. J Nutr Health Aging 2020 249 [Internet]. 2020 Oct 17 [cited 2023 Jul 20];24(9):920–7. Available from: https://link.springer.com/article/10.1007/s12603-020-1498-x.
Oviedo-Briones M, Laso ÁR, Carnicero JA, Cesari M, Grodzicki T, Gryglewska B, et al. A comparison of frailty assessment instruments in different clinical and social care settings: The frailtools project. J Am Med Dir Assoc [Internet]. 2021 Mar 1 [cited 2023 Jul 20;22(3):607.e7–607.e12. Available from: http://www.jamda.com/article/S1525861020308215/fulltext.
Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): A practical tool for identification of nutritional status. J Nutr Health Aging [Internet]. 2009[cited 2023 Jul 28;13(9):782–8. Available from: https://pubmed.ncbi.nlm.nih.gov/19812868/.
De Ulíbarri JI, González-Madroño A, De Villar NG, González P, González B, Mancha A, et al. CONUT: A tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38–45.
Dhillon RJS, Hasni S. Pathogenesis and management of sarcopenia. Clin Geriatr Med [Internet]. 2017 Feb 1 [cited 2023 Jun 15];33(1):17–26. Available from: http://www.geriatric.theclinics.com/article/S0749069016300714/fulltext.
Cruz-Jentoft AJ, Kiesswetter E, Drey M, Sieber CC. Nutrition, frailty, and sarcopenia. Aging Clin Exp Res [Internet]. 2017 Feb 1 [cited 2023 Jun 15];29(1):43–8. Available from: https://link.springer.com/article/10.1007/s40520-016-0709-0.
Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 6. Glycemic targets: Standards of care in diabetes—2023. Diabetes Care [Internet]. 2023 Jan 1 [cited 2023 May 29];46(Supplement_1):S97–110. Available from: https://diabetesjournals.org/care/article/46/Supplement_1/S97/148053/6-Glycemic-Targets-Standards-of-Care-in-Diabetes.
Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 13. Older adults: Standards of care in diabetes—2023. Diabetes Care [Internet]. 2023 Jan 1 [cited 2023 May 29];46(Supplement_1):S216–29. Available from: https://diabetesjournals.org/care/article/46/Supplement_1/S216/148044/13-Older-Adults-Standards-of-Care-in-Diabetes-2023.
Yoon JW, Ha YC, Kim KM, Moon JH, Choi SH, Lim S, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: The Korean longitudinal study on health and aging. Diabetes Metab J [Internet]. 2016 Apr 1 [cited 2023 May 29];40(2):140–6. Available from: http://www.e-dmj.org/journal/view.php?doi=10.4093/dmj.2016.40.2.0.
Porta M, Curletto G, Cipullo D, de la Longrais RR, Trento M, Passera P, et al. Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence. Diabetes Care [Internet]. 2014 Jun 1 [cited 2023 Jun 15];37(6):1668–74. https://doi.org/10.2337/dc13-2101.
Fukuda T, Bouchi R, Takeuchi T, Nakano Y, Murakami M, Minami I, et al. Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: A cross-sectional study. BMJ open diabetes Res care [Internet]. 2017 May 1 [cited 2023 May 29];5(1). Available from: https://pubmed.ncbi.nlm.nih.gov/28761661/.
Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes [Internet]. 2004 Jun [cited 2023 Jun 15];53(6):1543–8. Available from: https://pubmed.ncbi.nlm.nih.gov/15161759/.
Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles–a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia [Internet]. 2009[cited 2023 Jun 15;52(6):1182–91. Available from: https://pubmed.ncbi.nlm.nih.gov/19280173/.
Sundar VV, Ong SH, Easaw MEPM, Chee WSS. Sarcopenia with co-existent type 2 diabetes mellitus is associated with worse clinical outcomes among hospitalised cardiac patients. Clin Nutr ESPEN [Internet]. 2021 Dec 1 [cited 2023 May 29];46:380–5. Available from: https://pubmed.ncbi.nlm.nih.gov/34857224/.
Yabe D, Nishikino R, Kaneko M, Iwasaki M, Seino Y. Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events. Expert Opin Drug Saf [Internet]. 2015 Jun 1 [cited 2023 Jun 15;14(6):795–800. Available from: https://pubmed.ncbi.nlm.nih.gov/25851664/.
Rizzo MR, Barbieri M, Fava I, Desiderio M, Coppola C, Marfella R, et al. Sarcopenia in elderly diabetic patients: Role of dipeptidyl peptidase 4 inhibitors. J Am Med Dir Assoc [Internet]. 2016 Oct 1 [cited 2023 Jun 15];17(10):896–901. Available from: http://www.jamda.com/article/S1525861016301104/fulltext.
Perna S, Guido D, Bologna C, Solerte SB, Guerriero F, Isu A, et al. Liraglutide and obesity in elderly: Efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study. Aging Clin Exp Res [Internet]. 2016 Dec 1 [cited 2023 Jun 15;28(6):1251–7. Available from: https://pubmed.ncbi.nlm.nih.gov/26749118/.
Yajima T, Yajima K, Takahashi H, Yasuda K. The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis. J Diabetes Complications [Internet]. 2018 Aug 1 [cited 2023 Jul 27,;32(8):759–63. Available from: https://pubmed.ncbi.nlm.nih.gov/29937137/.
Ishii S, Nagai Y, Kato H, Fukuda H, Tanaka Y. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on muscle mass and the muscle/fat ratio in patients with type 2 diabetes. J Clin Med Res [Internet]. 2020 [cited 2023 Jul 27;12(2):122–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32095182/.
Rondanelli M, Perna S, Astrone P, Grugnetti A, Solerte SB, Guido D. Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus. Patient Prefer Adherence [Internet]. 2016 Mar 24 [cited 2023 Jul 27];10:407–13. Available from: https://pubmed.ncbi.nlm.nih.gov/27069358/.
Hong JY, Park KY, Kim BJ, Hwang WM, Kim DH, Lim DM. Effects of short-term exenatide treatment on regional fat distribution, glycated hemoglobin levels, and aortic pulse wave velocity of obese type 2 diabetes mellitus patients. Endocrinol Metab [Internet]. 2016 Mar 1 [cited 2023 Jul 27];31(1):80–5. Available from: http://www.e-enm.org/journal/view.php?doi=10.3803/EnM.2016.31.1.80.
Ozeki Y, Masaki T, Kamata A, Miyamoto S, Yoshida Y, Okamoto M, et al. The effectiveness of GLP-1 receptor agonist semaglutide on body composition in elderly obese diabetic patients: A pilot study. Med (Basel, Switzerland) [Internet]. 2022 Sep 16 [cited 2023 Jul 27];9(9):47. Available from: https://pubmed.ncbi.nlm.nih.gov/36135828/.
Osaka T, Hamaguchi M, Fukui M. Favorable appendicular skeletal muscle mass changes in older patients with type 2 diabetes receiving GLP-1 receptor agonist and basal insulin co-therapy. Clin Med Insights Endocrinol Diabetes [Internet]. 2023 Jan 1 [cited 2023 Jul 27];16. Available from: https://pubmed.ncbi.nlm.nih.gov/37025567/.
Zhang X, Zhao Y, Chen S, Shao H. Anti-diabetic drugs and sarcopenia: Emerging links, mechanistic insights, and clinical implications. J Cachexia Sarcopenia Muscle [Internet]. 2021 Dec 1 [cited 2023 Jul 20;12(6):1368–79. Available from: https://pubmed.ncbi.nlm.nih.gov/34676695/.
Massimino E, Izzo A, Riccardi G, Della Pepa G. The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: Current evidence and underlying mechanisms. Cells. 2021;10(8).
Bouchi R, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, et al. Insulin treatment attenuates decline of muscle mass in Japanese patients with type 2 diabetes. Calcif Tissue Int [Internet]. 2017 Jul 1 [cited 2023 Jun 15;101(1):1–8. Available from: https://kyushu-u.elsevierpure.com/ja/publications/insulin-treatment-attenuates-decline-of-muscle-mass-in-japanese-p.
Lee CG, Boyko EJ, Barrett-Connor E, Miljkovic I, Hoffman AR, Everson-Rose SA, et al. Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care [Internet]. 2011 Nov 1 [cited 2023 Jun 15;34(11):2381–6. https://doi.org/10.2337/dc11-1032.
Laksmi PW, Setiati S, Tamin TZ, Soewondo P, Rochmah W, Nafrialdi N, et al. Effect of metformin on handgrip strength, gait speed, myostatin serum level, and health-related quality of life: A double blind randomized controlled trial among non-diabetic pre-frail elderly patients. Acta Med Indones [Internet]. 2017 Aug 8 [cited 2023 Jun 15];49(2):118. Available from: https://www.actamedindones.org/index.php/ijim/article/view/330.
Lee CG, Schwartz AV, Yaffe K, Hillier TA, Leblanc ES, Cawthon PM. Changes in physical performance in older women according to presence and treatment of diabetes mellitus. J Am Geriatr Soc [Internet]. 2013 Nov 1 [cited 2023 Jun 15;61(11):1872–8. Available from: https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1111/jgs.12502.
Rajaobelina K, Helmer C, Vélayoudom-Céphise FL, Nov S, Farges B, Pupier E, et al. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes. Diabetes Metab Res Rev [Internet]. 2017 Oct 1 [cited 2023 Jun 15];33(7). Available from: https://pubmed.ncbi.nlm.nih.gov/28719154/.
Sencan C, Dost FS, Ates Bulut E, Isik AT. DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients. Exp Gerontol [Internet]. 2022 Jul 1 [cited 2023 Jul 27];164. Available from: https://pubmed.ncbi.nlm.nih.gov/35526704/.
Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic retinopathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412–8.
Article PubMed PubMed Central Google Scholar
Rossi AP, Fantin F, Micciolo R, Bertocchi M, Bertassello P, Zanandrea V, et al. Identifying sarcopenia in acute care setting patients. J Am Med Dir Assoc [Internet]. 2014 [cited 2023 Jun 16];15(4):303.e7–303.e12 . Available from: https://pubmed.ncbi.nlm.nih.gov/24508329/.
Steiber N. Strong or Weak Handgrip? Normative reference values for the german population across the life course stratified by sex, age, and body height. PLoS One [Internet]. 2016 Oct 1 [cited 2023 Jun 16];11(10). Available from: https://pubmed.ncbi.nlm.nih.gov/27701433/.
Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr [Internet]. 2016 [cited 2023 Jun 16];16(1):1–10. Available from: https://pubmed.ncbi.nlm.nih.gov/27716195/.
Ibrahim K, May C, Patel HP, Baxter M, Sayer AA, Roberts H. A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): Study protocol. Pilot Feasibility Stud [Internet]. 2016 Sep 23 [cited 2023 Jun 16];2(1). Available from: https://pubmed.ncbi.nlm.nih.gov/27965846/.
Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet (London, England) [Internet]. 2015 Jul 18 [cited 2023 Jun 16];386(9990):266–73. Available from: https://pubmed.ncbi.nlm.nih.gov/25982160/.
Koo BK, Moon S, Moon MK. Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: A prospective cohort study. BMC Geriatr [Internet]. 2021 Dec 1 [cited 2023 May 29];21(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34876063/.
Chen CN, Chen TC, Tsai SC, Hwu CM. Factors associated with relative muscle strength in patients with type 2 diabetes mellitus. Arch Gerontol Geriatr [Internet]. 2021 Jul 1 [cited 2023 May 29];95. Available from: https://pubmed.ncbi.nlm.nih.gov/33740478/.
Chen S, Yan S, Aiheti N, Kuribanjiang K, Yao X, Wang Q, et al. A bi-directional Mendelian randomization study of sarcopenia-related traits and type 2 diabetes mellitus. Front Endocrinol (Lausanne) [Internet]. 2023 Mar 8 [cited 2023 May 29];14. Available from: https://pubmed.ncbi.nlm.nih.gov/36967750/.
Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall H, Cooper C, et al. A review of the measurement of grip strength in clinical and epidemiological studies: Towards a standardised approach. Age Ageing [Internet]. 2011 Jul [cited 2023 Aug 30;40(4):423–9. Available from: https://pubmed.ncbi.nlm.nih.gov/21624928/.
Mateo Lázaro ML, Penacho Lázaro MA, Berisa Losantos F, Plaza Bayo A. Nuevas tablas de fuerza de la mano para población adulta de Teruel. Nutr Hosp. 2008;23(1):35–40.
Sánchez Torralvo FJ, Porras N, Abuín Fernández J, García Torres F, Tapia MJ, Lima F, et al. Valores de normalidad de dinamometría de mano en España. Relación con la masa magra. Nutr Hosp. 2018;35(1):98–103.
留言 (0)